BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 2148772)

  • 1. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
    de la Monte SM; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of neurones from cortical and subcortical areas in Down's syndrome patients at middle age. Quantitative comparisons with younger Down's patients and patients with Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B; Ravindra CR
    J Neurol Sci; 1987 Aug; 80(1):79-89. PubMed ID: 2956368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
    Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
    Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
    Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
    Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease and Down's syndrome.
    Mann DM
    Histopathology; 1988 Aug; 13(2):125-37. PubMed ID: 2971602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebral degeneration in Down's syndrome].
    Hirabayashi K; Ikeda K; Shimokawa K; Orthner H
    Folia Psychiatr Neurol Jpn; 1979; 33(1):81-96. PubMed ID: 156670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amygdala in Down's syndrome and familial Alzheimer's disease: four clinicopathological case reports.
    Murphy GM; Ellis WG
    Biol Psychiatry; 1991 Jul; 30(1):92-106. PubMed ID: 1832566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes.
    Mann DM; Yates PO; Marcyniuk B
    Neuropathol Appl Neurobiol; 1984; 10(3):185-207. PubMed ID: 6234474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age.
    Mann DM; Yates PO; Marcyniuk B
    J Neurol Sci; 1985 Jul; 69(3):139-59. PubMed ID: 3162000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of Down's syndrome and Alzheimer's neuropathology on default mode connectivity.
    Wilson LR; Vatansever D; Annus T; Williams GB; Hong YT; Fryer TD; Nestor PJ; Holland AJ; Zaman SH
    Hum Brain Mapp; 2019 Oct; 40(15):4551-4563. PubMed ID: 31350817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
    Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
    Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of the nucleus basalis in Down's syndrome.
    Casanova MF; Walker LC; Whitehouse PJ; Price DL
    Ann Neurol; 1985 Sep; 18(3):310-3. PubMed ID: 2932050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topography of neurofibrillary tangles and granulovacuoles in hippocampi of patients with Down's syndrome: quantitative comparison with normal ageing and Alzheimer's disease.
    Ball MJ; Nuttall K
    Neuropathol Appl Neurobiol; 1981; 7(1):13-20. PubMed ID: 6453301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease in Down's syndrome. A review.
    Karlinsky H
    J Am Geriatr Soc; 1986 Oct; 34(10):728-34. PubMed ID: 2944942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.
    Furuta A; Price DL; Pardo CA; Troncoso JC; Xu ZS; Taniguchi N; Martin LJ
    Am J Pathol; 1995 Feb; 146(2):357-67. PubMed ID: 7856748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.
    Godridge H; Reynolds GP; Czudek C; Calcutt NA; Benton M
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):775-8. PubMed ID: 2440994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Lewy bodies in Trisomy 21 (Down's syndrome).
    Raghavan R; Khin-Nu C; Brown A; Irving D; Ince PG; Day K; Tyrer SP; Perry RH
    Can J Neurol Sci; 1993 Feb; 20(1):48-51. PubMed ID: 8467429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.